Arcadium Lithium PLC

LTM

Arcadium Lithium Plc operates as a lithium chemicals production company. The company is headquartered in Shannon, Clare and currently employs 2,909 full-time employees. The company went IPO on 2023-12-22. The Company’s diverse set of products include lithium hydroxide, carbonate, spodumene and specialties. The firm produces a diverse set of lithium products, such as lithium specialties, lithium hydroxide, lithium carbonate, and spodumene. The Company’s products applications include butyllithium, purified metals, specialty organics, battery grade lithium hydroxide, other lithium hydroxide, battery grade lithium carbonate, other lithium carbonate, and intermediate product for conversion to lithium hydroxide/carbonate. The company also focuses on conventional brine extraction, direct lithium brine extraction, hard rock mining, chemical processing and production of battery grade and specialty lithium products. The company has a presence in three lithium extraction geographies, including the South American Lithium Triangle, Western Australia and Canada.

LTR Pharma Limited

LTP

LTR Pharma Ltd. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Brisbane, Queensland. The company went IPO on 2023-12-11. The firm is focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction (ED). Its lead product SPONTAN is set apart from existing ED therapies by its mechanism of action-intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work in 10 minutes or less. SPONTAN (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction.